Bulletin from the annual general meeting in Peptonic Medical AB (publ)
Summary
Peptonic Medical held its annual general meeting on 24 June 2026 in Stockholm. Shareholders approved the 2025 financial statements and resolved that no dividend will be paid for the 2025 financial year. The meeting also discharged the board and CEO from liability, set the board size at four members, and approved board and auditor remuneration. Shareholders re-elected three board members, elected Carina Lindqvist as a new director, re-elected Anders Blom as chairman, and reappointed KPMG as auditor. The board also received authorization to issue shares, warrants, or convertibles to raise capital or support strategic collaborations and acquisitions.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected